Jennifer Miller, PhD holds a doctorate in microbiology, immunology, and molecular genetics. She is a highly experienced microbiologist with over 20 years of expertise in vector-borne and zoonotic pathogens, including Borrelia burgdorferi, Leptospira interrogans, and Bartonella species. She leads clinical assay development and CLIA validation efforts and oversees the diagnostic test portfolio at Galaxy Diagnostics. CLIA-certified, high-complexity, laboratory-developed assays commercially launched under Jennifer Miller’s direction include serological, molecular diagnostic, and direct antigen tests for vector-borne pathogens, including LymeBorrelia and Bartonella species. She also oversees in-house, collaborative, contract, foundation, and federally funded research and development efforts. Jennifer Miller’s work has been pivotal in advancing the company’s diagnostic capabilities, drawing from her diverse experience in research and clinical testing.